XML 21 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Equity (Deficit) - USD ($)
shares in Thousands, $ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated deficit
Treasury stock, at cost
Non-controlling interests
Beginning balance (in shares) at Dec. 31, 2022   25,413        
Beginning balance at Dec. 31, 2022 $ (118,874) $ 25,413 $ 149,348 $ 118,948 $ (413,358) $ 775
Increase (Decrease) in Equity            
Net Income (Loss) (56,062)     (56,290)   228
Distributions to non-controlling interest holders (388)         (388)
Reclassification of warrant liability to equity 6,951   6,951      
Share-based compensation expense 5,068   5,068      
Issuance of common stock, net of issuance costs (in shares)   4,550        
Issuance of common stock, net of issuance costs 20,461 $ 4,550 15,911      
Exercise of Warrants, net of costs 18,321     (228,322) 246,643  
Issuance of restricted share units and restricted shares 0     (10,071) 10,071  
Treasury shares withheld for the payment of tax on restricted share unit and restricted share issuances (532)     (4,427) 3,895  
Ending balance (in shares) at Dec. 31, 2023   29,963        
Ending balance at Dec. 31, 2023 (125,055) $ 29,963 177,278 (180,162) (152,749) 615
Increase (Decrease) in Equity            
Net Income (Loss) (35,448)     (35,636)   188
Distributions to non-controlling interest holders (138)         (138)
Share-based compensation expense 4,737   4,737      
Exercise of Warrants, net of costs (90)   (418) (3,893) 4,221  
Issuance of restricted share units and restricted shares 0     (26,805) 26,805  
Treasury shares withheld for the payment of tax on restricted share unit and restricted share issuances (717)     (13,481) 12,764  
Ending balance (in shares) at Dec. 31, 2024   29,963        
Ending balance at Dec. 31, 2024 $ (156,711) $ 29,963 $ 181,597 $ (259,977) $ (108,959) $ 665